The potential of mesothelial cells in tissue engineering and regenerative medicine applications

International Journal of Artificial Organs

Volumn 30, Issue 6, 2007, Pages 527-540

  Herrick, Sarah E ^a   Mutsaers, S E ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Differentiation; Mesothelium; Progenitor cell; Serosa; Surgery

Indexed keywords

ADHESION; CELL ENGINEERING; CELLS; CYTOLOGY; REGENERATIVE MEDICINE; REPAIR; SURGERY; TISSUE; TISSUE ENGINEERING;

ADHESION FORMATIONS; DIFFERENTIATION; INTRAPERITONEAL; MEDICINE APPLICATION; MESOTHELIAL CELLS; MESOTHELIUM; PROGENITOR CELL; REGENERATIVE MEDICINE; SEROSA; TISSUES ENGINEERINGS;

FLUORIDATION;

ADHESION; BLOOD VESSEL; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; HUMAN; INFECTION; MESOTHELIUM; MESOTHELIUM CELL; NONHUMAN; PERIPHERAL NERVE; PLASTICITY; RADIATION INJURY; REGENERATIVE MEDICINE; REVIEW; SEROSA; STEM CELL; SURGICAL INJURY; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR;

EID: 34547867788     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000611     Document Type: Review

References (94)

1. Holmdahl L, Risberg B, Beck DE, et al. Adhesions: Pathogenesis and prevention-panel discussion and summary. Eur J Surg 1997; 577 (suppl): S56-62.
2. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: A retrospective cohort study. Lancet 1999; 353: 1476-80.
3. Herrick SE, Mutsaers SE, Ozua P, et al. Human peritoneal adhesions are highly cellular, innervated, and vascularized. J Pathol 2000; 192: 67-72.
4. Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VW, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: The role of mesothelial cells. Nephrol Dial Transplant 1995; 10: 677-83.
5. Mutsaers SE. Mesothelial cells: Their structure, function and role in serosal repair. Respirology 2002; 7: 171-91.
6. Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, Mutsaers SE. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 2002; 115 (Pt 7): 1383-9.
7. Diaz C, Selgas R, Castro MA, et al. Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: Its relationship with peritoneal antecedents and functional parameters. Adv Perit Dial 1998; 14: 19-24.
8. Di Paolo N, Vanni L, Sacchi G. Autologous implant of peritoneal mesothelium in rabbits and man. Clin Nephrol 1990; 34: 179-84.
9. Di Paolo N, Sacchi G, Vanni L, et al. Autologous peritoneal mesothelial cell implant in rabbits and peritoneal dialysis patients. Nephron 1991; 57: 323-31.
10. Bertram P, Tietze L, Hoopmann M, Treutner KH, Mittermayer C, Schumpelick V. Intraperitoneal transplantation of isologous mesothelial cells for prevention of adhesions. Eur J Surg 1999; 165: 705-9.
11. Hekking LH, Harvey VS, Havenith CE, et al. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis. Perit Dial int 2003; 23: 323-30.
12. Nagy JA, Shockley TR, Masse EM, Harvey VS, Hoff CM, Jackman RW. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther 1995; 2: 402-10.
13. Mutsaers SE, Whitaker D, Papadimitriou JM. Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model. Am J Pathol 2002; 160: 681-92.
14. Adamson IY, Bakowska J, Prieditis H. Proliferation of rat pleural mesothelial cells in response to hepatocyte and keratinocyte growth factors. Am J Respir Cell Mol Biol 2000; 23: 345-9.
15. Warn R, Harvey P, Warn A, et al. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways. Exp Cell Res 2001; 267: 258-66.
16. Naiki Y, Matsuo K, Matsuoka T, Maeda Y. Possible role of hepatocyte growth factor in regeneration of human peritoneal mesothelial cells. Int J Artif Organs 2005; 28: 141-9.
17. Matsuo K, Maeda Y, Naiki Y, et al. Possible effects of hepatocyte growth factor for the prevention of peritoneal fibrosis. Nephron Exp Nephrol 2005; 99: e87-94.
18. Liu HJ, Wu CT, Duan HF, Wu B, Lu ZZ, Wang L. Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model. Surgery 2006; 140: 441-7.
19. Zhu Z, Yao J, Wang F, Xu Q. TNF-alpha and the phenotypic transformation of human peritoneal mesothelial cell. Chin Med J (Engl) 2002; 115: 513-7.
20. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63: 1530-9.
21. Gulyas M, Dobra K, Hjerpe A. Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells. Differentiation 1999; 65: 89-96.
22. Gulyas M, Hjerpe A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol 2003; 199: 479-87.
23. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-13.
24. Jimenez-Heffernan JA, Aguilera A, Aroeira LS, et al. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch 2004; 444: 247-56.
25. Aguilera A, Yanez-Mo M, Selgas R, Sanchez-Madrid F, Lopez-Cabrera M. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Invest Drugs 2005; 6: 262-8.
26. Margetts PJ, Oh KH, Kolb M. Transforming growth factor-beta: Importance in long-term perioneal membrane changes. Perit Dial Int 2005; 25 (suppl 3): S15-7.
27. De Vriese AS, Tilton RG, Mortier S, Lameire NH. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 2006; 21: 2549-55.
28. Vargha R, Endemann M, Kratochwill K, et al. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006; 21: 2943-7.
29. Munoz-Chapuli R, Perez-Pomares JM, Macias D, Garcia-Garrido L, Carmona R, Gonzalez M. Differentiation of hemangioblasts from embryonic mesothelial cells? A model on the origin of the vertebrate cardiovascular system. Differentiation 1999; 64: 133-41.
30. Perez-Pomares JM, Munoz-Chapuli R. Epithelial-mesenchymal transitions: A mesodermal cell strategy for evolutive innovation in Metazoans. Anat Rec 2002; 268: 343-51.
31. Perez-Pomares JM, Carmona R, Gonzalez-Iriarte M, Macias D, Guadix JA, Munoz-Chapuli R. Contribution of mesothelium-derived cells to liver sinusoids in avian embryos. Dev Dyn 2004; 229: 465-74.
32. Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM. The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 2005; 132: 5317-28.
33. Wada AM, Smith TK, Osler ME, Reese DE, Bader DM. Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res 2003; 92: 525-31.
34. Elmadbouh I, Chen Y, Louedec L, et al. Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function. Cardiovasc Res 2005; 68: 307-17.
35. Drakontides AB, Danon MJ, Levine S. Heterotopic neogenesis of skeletal muscle induced in the adult rat diaphragmatic peritoneum: Ultrastructural and transplantation studies. Histol Histopathol 1999; 14: 1135-43.
36. Donna A, Betta PG. Differentiation towards cartilage and bone in a primary tumour of pleura. Further evidence in support of the concept of mesodermoma. Histopathology 1986; 10: 101-8.
37. Kiyozuka Y, Miyazaki H, Yoshizawa K, et al. An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: Bone morphogenetic protein-2 in mesothelial cells and its tumor. Dig Dis Sci 1999; 44: 1626-31.
38. Chalabreysse L, Guillaud C, Tabib A, Loire R, Thivolet-Bejui F. [Malignant mesothelioma with osteoblastic heterologous elements]. Ann Pathol 2001; 21: 428-30. French.
39. Rittinghausen S, Ernst H, Muhle H, Mohr U. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp Toxicol Pathol 1992; 44: 55-8.
40. Lemeshev Y, Lahr CJ, Denton J, Kent SP, Diethelm AG. Heterotopic bone formation associated with intestinal obstruction and small bowel resection. Ala J Med Sci 1983; 20: 314-7.
41. Wilson JD, Montague CJ, Salcuni P, Bordi C, Rosai J. Heterotopic mesenteric ossification ("intraabdominal myositis ossificans"): report of five cases. Am J Surg Pathol 1999; 23: 1464-70.
42. Fadare O, Bifulco C, Carter D, Parkash V. Cartilaginous differentiation in peritoneal tissues: A report of two cases and a review of the literature. Mod Pathol 2002; 15: 777-80.
43. Weibel MA, Majno G. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg 1973; 126: 345-53.
44. Goldsmith HS, Griffith AL, Kupferman A, Catsimpoolas N. Lipid angiogenic factor from omentum. JAMA 1984; 252: 2034-6.
45. Dujovny M, Ding YH, Ding Y, Agner C, Perez-Arjona E. Current concepts on the expression of neurotrophins in the greater omentum. Neurol Res 2004; 26: 226-9.
46. Garcia-Gomez I, Goldsmith HS, Angulo J, et al. Angiogenic capacity of human omental stem cells. Neurol Res 2005; 27: 807-11.
47. Goldsmith HS, Chen WF, Duckett SW. Brain vascularization by intact omentum. Arch Surg 1973; 106: 695-8.
48. Goldsmith HS, Duckett S, Chen WF. Prevention of cerebral infarction in the dog by intact omentum. Am J Surg 1975; 130: 317-20.
49. Matoba Y, Katayama H, Ohami H. Evaluation of omental implantation for perforated gastric ulcer therapy: Findings in a rat model. J Gastroenterol 1996; 31: 777-84.
50. Chamorro M, Carceller F, Llanos C, Rodriguez-Alvarino A, Colmenero C, Burgueno M. The effect of omental wrapping on nerve graft regeneration. Br J Plast Surg 1993; 46: 426-9.
51. Castaneda F, Kinne RK. Omental graft improves functional recovery of transected peripheral nerve. Muscle Nerve 2002; 26: 527-32.
52. Israelsson LA, Jonsson T. Incisional hernia after midline laparotomy: A prospective study. Eur J Surg 1996; 162: 125-9.
53. Sheen AJ. Prosthetics in hernia repair. Surg Today 2005; 35: 196-8.
54. Luijendijk RW, Hop WC, van den Tol MP, et al. A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 2000; 343: 392-8.
55. van't Riet M, de Vos van Steenwijk PJ, Bonthuis F, et al. Prevention of adhesion to prosthetic mesh: Comparison of different barriers using an incisional hernia model. Ann Surg 2003; 237: 123-8.
56. Balique JG, Benchetrit S, Bouillot JL, et al. Intraperitoneal treatment of incisional and umbilical hernias using an innovative composite mesh: Four-year results of a prospective multicenter clinical trial. Hernia 2005; 9: 68-74.
57. Bristow RE, Montz FJ. Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier. Gynecol Oncol 2005; 99: 301-8.
58. Felemovicius I, Bonsack ME, Hagerman G, Delaney JP. Prevention of adhesions to polypropylene mesh. J Am Coll Surg 2004; 198: 543-8.
59. Menon NG, Rodriguez ED, Byrnes CK, Girotto JA, Goldberg NH, Silverman RP. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 2003; 50: 523-7.
60. Butler CE, Prieto VG. Reduction of adhesions with composite alloDerm/ polypropylene mesh implants for abdominal wall reconstruction. Plast Reconstr Surg 2004; 114: 464-73.
61. Lai PH, Chang Y, Liang HC, Chen SC, Wei HJ, Sung HW. Peritoneal regeneration induced by an acellular bovine pericardial patch in the repair of abdominal wall defects. J Surg Res 2005; 127: 85-92.
62. Chang Y, Lai PH, Wang CC, Chen SC, Chang WC, Sung HW. Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial adhesions. J Thorac Cardiovasc Surg 2006; 132: 867-74.
63. Lai JY, Chang PY, Lin JN. Body wall repair using small intestinal submucosa seeded with cells. J Pediatr Surg 2003; 38: 1752-5.
64. Sekine H, Shimizu T, Kosaka S, Kobayashi E, Okano T. Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J Heart Lung Transplant 2006; 25: 324-32.
65. Bellon JM, Garcia-Honduvilla N, Lopez R, Corrales C, Jurado F, Bujan J. In vitro mesothelialization of prosthetic materials designed for the repair of abdominal wall defects. J Mater Sci Mater Med 2003; 14: 359-64.
66. Matthews BD, Pratt BL, Pollinger HS, et al. Assessment of adhesion formation to intra-abdominal polypropylene mesh and polytetrafluoroethylene mesh. J Surg Res 2003; 114: 126-32.
67. Whitaker D, Papadimitriou J. Mesothelial healing: Morphological and kinetic investigations. J Pathol 1985; 145: 159-75.
68. Fotev Z, Whitaker D, Papadimitriou JM. Role of macrophages in mesothelial healing. J Pathol 1987; 151: 209-19.
69. Mutsaers SE, Whitaker D, Papadimitriou JM. Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model. Am J Pathol 2002; 160: 681-92.
70. Raftery AT. Regeneration of parietal and visceral peritoneum in the immature animal: A light and electron microscopical study. Br J Surg 1973; 60: 969-75.
71. Kuga H, Morisaki T, Nakamura K, et al. Construction of a transplantable tissue-engineered artificial peritoneum. Eur Surg Res 2004; 36: 323-30.
72. Takazawa R, Yamato M, Kageyama Y, Okano T, Kihara K. Mesothelial cell sheets cultured on fibrin gel prevent adhesion formation in an intestinal hernia model. Tissue Eng 2005; 11: 618-25.
73. Asano T, Takazawa R, Yamato M, et al. Transplantation of an autologous mesothelial cell sheet prepared from tunica vaginalis prevents post-operative adhesions in a canine model. Tissue Eng 2006; 12: 2629-37.
74. Eskeland G, Eskeland T. Development of mesothelium on the outer surface of intraperitoneal diffusion chambers. Acta Pathol Microbiol Scand 1966; 66: 447-64.
75. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999; 85: 1173-8.
76. Chue WL, Campbell GR, Caplice N, et al. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J Vasc Surg 2004; 39: 859-67.
77. Moldovan NI, Havemann K. Transdifferentiation, a potential mechanism for covering vascular grafts grown within recipient's peritoneal cavity with endothelial-like cells. Circ Res 2002; 91: el.
78. Dahlin LB, Lundborg G. Use of tubes in peripheral nerve repair. Neurosurg Clin N Am 2001; 12: 341-52.
79. Lundborg G, Dahlin LB, Danielsen N, et al. Nerve regeneration across an extended gap: A neurobiological view of nerve repair and the possible involvement of neuronotrophic factors. J Hand Surg (Am) 1982; 7: 580-7.
80. Danielsen N, Dahlin LB, Lee YF, Lundborg G. Axonal growth in mesothelial chambers. The role of the distal nerve segment. Scand J Plast Reconstr Surg 1983; 17: 119-25.
81. Danielsen N, Lundborg G, Frizell M. Nerve repair and axonal transport: Outgrowth delay and regeneration rate after transection and repair of rabbit hypoglossal nerve. Brain Res 1986; 376: 125-32.
82. Castaneda F, Kinne RK. Omental graft improves functional recovery of transected peripheral nerve. Muscle Nerve 2002; 26: 527-32.
83. Jackman RW, Stapleton TD, Masse EM, et al. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium in vivo: directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin. Hum Gene Ther 1998; 9: 1069-81.
84. Murphy JE, Rheinwald JG. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy. Hum Gene Ther 1997; 8: 1867-79.
85. Nagy JA, Shockley TR, Masse EM, Harvey VS, Hoff CM, Jackman RW. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther 1995; 2: 402-10.
86. Setoguchi Y, Jaffe HA, Chu CS, Crystal RG. Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation. Am J Respir Cell Mol Biol 1994; 10: 369-77.
87. Osada S, Ebihara I, Setoguchi Y, Takahashi H, Tomino Y, Koide H. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene. Kidney Int 1999; 55: 1234-40.
88. Hoff CM, Cusick JL, Masse EM, Jackman RW, Nagy JA, Shockley TR. Modulation of transgene expression in mesothelial cells by activation of an inducible promoter. Nephrol Dial Transplant 1998; 13: 1420-9.
89. Einbinder T, Sufaro Y, Yusim I, et al. Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells. Kidney Int 2003; 63: 2103-12.
90. Rancourt C, Bergeron C, Lane D, Garon G, Piche A. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Cytotherapy 2003; 5: 509-22.
91. Devin CJ, Lee YC, Light RW, Lane KB. Pleural space as a site of ectopic gene delivery: Transfection of pleural mesothelial cells with systemic distribution of gene product. Chest 2003; 123: 202-8.
92. Mae M, Crystal RG. Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma. Hum Gene Ther 2002; 13: 1471-82.
93. Yoshida T, Sheng HM, Sawada H. Use of abdominal wall with mesothelium as a substrate for reconstitution of urinary bladder wall: Replacement of the mesothelium by the urothelium and complete bladder wall reconstruction. Scand J Urol Nephrol 2005; 39: 148-53.
94. Bukovsky A, Svetlikova M, Caudle MR. Oogenesis in cultures derived from adult human ovaries. Reprod Biol Endocrinol 2005; 3: 17.